Assignee
NAVIGO PROTEINS GMBH
DE·13 granted patents·17 pending applications·21 citations·filing 2016–2025
Top patents by PatentIndex Score
30 records- 0189US11230576B2Alkaline stable immunoglobulin-binding proteinsNAVIGO PROTEINS GMBH·Filed 2017·Granted Jan 25, 2022·7 cites·21 claims
- 0289US10808042B2Immunoglobulin-binding proteins and their use in affinity purificationNAVIGO PROTEINS GMBH·Filed 2016·Granted Oct 20, 2020·7 cites·11 claims
- 0382US10858405B2EGFR binding proteinsNAVIGO PROTEINS GMBH·Filed 2016·Granted Dec 8, 2020·5 cites·10 claims
- 0474US11813336B2Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linkerNAVIGO PROTEINS GMBH·Filed 2017·Granted Nov 14, 2023·1 cites·13 claims
- 0571US2026078155A1Novel folr1 specific binding proteins for cancer diagnosis and treatmentNAVIGO PROTEINS GMBH·Filed 2025·Application pending·0 cites
- 0667US12509493B2FOLR1 specific binding proteins for cancer diagnosis and treatmentNAVIGO PROTEINS GMBH·Filed 2019·Granted Dec 30, 2025·0 cites·14 claims
- 0765US10584152B2Binding proteins based on di-ubiquitin muteins and methods for generationNAVIGO PROTEINS GMBH·Filed 2016·Granted Mar 10, 2020·1 cites·24 claims
- 0862US2025388696A1Fusion proteins with half life extending domainsNAVIGO PROTEINS GMBH·Filed 2023·Application pending·0 cites
- 0956US12286458B2Binding proteins for the enzyme acid alpha glucosidase (GAA) and uses thereofNAVIGO PROTEINS GMBH·Filed 2020·Granted Apr 29, 2025·0 cites·15 claims
- 1055US12570690B2Immunoglobulin binding proteins for affinity purificationNAVIGO PROTEINS GMBH·Filed 2021·Granted Mar 10, 2026·0 cites·13 claims
- 1152US2023272050A1Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (sars-cov-2)NAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 1252US2024117010A1Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (sars-cov-2)NAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 1350US12577276B2Immunoglobulin binding proteins for affinity purificationNAVIGO PROTEINS GMBH·Filed 2020·Granted Mar 17, 2026·0 cites·14 claims
- 1449US12552832B2Immunoglobulin binding polypeptidesNAVIGO PROTEINS GMBH·Filed 2021·Granted Feb 17, 2026·0 cites·14 claims
- 1549US12466857B2Triple-helical polypeptides lacking binding affinity for the Fc domain of immunoglobulin and uses thereofNAVIGO PROTEINS GMBH·Filed 2019·Granted Nov 11, 2025·0 cites·8 claims
- 1649US11208436B2Populations of polypeptides having a triple-helical structureNAVIGO PROTEINS GMBH·Filed 2019·Granted Dec 28, 2021·0 cites·10 claims
- 1748US2024209098A1Fusion proteins with specifity for type ii collagen and vegf-a for the treatment of eye diseasesNAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 1848US2023322946A1Serum stable binding proteins for human her2 for theranostic applicationsNAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 1948US2024309056A1Affinity ligands for the purification and detection of ubiquitin muteinsNAVIGO PROTEINS GMBH·Filed 2022·Application pending·0 cites
- 2048US2024352076A1Specific baculovirus major envelope glycoprotein gp64 binding proteinsNAVIGO PROTEINS GMBH·Filed 2022·Application pending·0 cites
- 2147US2025304654A1High affinity purification of ferritinNAVIGO PROTEINS GMBH·Filed 2023·Application pending·0 cites
- 2247US2023416345A1New type ii collagen binding proteinsNAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 2347US2019292266A1Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragmentsNAVIGO PROTEINS GMBH·Filed 2019·Application pending·0 cites
- 2445US2023416313A1Binding proteins for complement factor h (cfh)NAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 2544US2024218032A1Novel human programmed death ligand 1 (pd-l1) specific binding moleculesNAVIGO PROTEINS GMBH·Filed 2022·Application pending·0 cites
- 2643US2023093429A1AFFINITY LIGAND FOR THE SOLUBLE PART OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 (sFGFR3)NAVIGO PROTEINS GMBH·Filed 2021·Application pending·0 cites
- 2743US2022168386A1Novel psma specific binding proteins for cancer diagnosis and treatmentNAVIGO PROTEINS GMBH·Filed 2020·Application pending·0 cites
- 2839US11414466B2Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancerNAVIGO PROTEINS GMBH·Filed 2018·Granted Aug 16, 2022·0 cites·10 claims
- 2938US2018030140A1Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragmentsNAVIGO PROTEINS GMBH·Filed 2016·Application pending·0 cites
- 3029US2018273636A1Her2 binding proteins based on di-ubiquitin muteinsNAVIGO PROTEINS GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAVIGO PROTEINS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →